Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Non-Current Assets (2020 - 2024)

Immuneering (IMRX) has 5 years of Other Non-Current Assets data on record, last reported at $1.3 million in Q3 2024.

  • For Q3 2024, Other Non-Current Assets rose 74.23% year-over-year to $1.3 million; the TTM value through Sep 2024 reached $1.3 million, up 74.23%, while the annual FY2023 figure was $1.0 million, 39.09% up from the prior year.
  • Other Non-Current Assets reached $1.3 million in Q3 2024 per IMRX's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.3 million in Q3 2024 and bottomed at $14333.0 in Q4 2020.
  • Average Other Non-Current Assets over 5 years is $650662.8, with a median of $743703.0 recorded in 2022.
  • The widest YoY moves for Other Non-Current Assets: up 5044.02% in 2022, down 90.67% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $14333.0 in 2020, then skyrocketed by 612.54% to $102129.0 in 2021, then soared by 628.2% to $743703.0 in 2022, then skyrocketed by 39.09% to $1.0 million in 2023, then grew by 25.26% to $1.3 million in 2024.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $1.3 million in Q3 2024, $1.2 million in Q2 2024, and $1.2 million in Q1 2024.